Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-20-000485

← back to feed
Filed
Aug 19, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Aug 17, 2020 54.1M sh
Current Liabilities Q3 2020 · Jun 30, 2020 $1.2M
Current Liabilities Q3 2020 · Sep 30, 2019 $1.29M
Total Liabilities Q3 2020 · Jun 30, 2020 $2.49M
Total Liabilities Q3 2020 · Sep 30, 2019 $2.53M
Current Assets Q3 2020 · Jun 30, 2020 $444.2K
Current Assets Q3 2020 · Sep 30, 2019 $379.81K
Total Assets Q3 2020 · Jun 30, 2020 $1.37M
Total Assets Q3 2020 · Sep 30, 2019 $1.29M
Capex Q3 2020 · Jun 30, 2019 $25.68K
Operating Cash Flow Q3 2020 · Jun 30, 2019 −$464.03K
Cash And Equivalents Q3 2020 · Jun 30, 2019 $53.78K
Cash And Equivalents Q3 2020 · Sep 30, 2018 $68.32K
Stockholders Equity Q3 2020 · Jun 30, 2019 −$1.17M
Stockholders Equity restated Q3 2020 · Mar 31, 2019 $28.61M
Stockholders Equity Q3 2020 · Sep 30, 2018 −$700.45K
Net Income Q3 2020 · Jun 30, 2019 −$344.44K
Net Income Q3 2020 · Jun 30, 2019 −$990.97K
Operating Income Q3 2020 · Jun 30, 2019 −$309.13K
Operating Income Q3 2020 · Jun 30, 2019 −$893.84K
Gross Profit Q3 2020 · Jun 30, 2019 $10.31K
Gross Profit Q3 2020 · Jun 30, 2019 $144.35K
Cost Of Revenue Q3 2020 · Jun 30, 2019 $2.45K
Cost Of Revenue Q3 2020 · Jun 30, 2019 $28.12K
Revenue Q3 2020 · Jun 30, 2019 $12.76K
Revenue Q3 2020 · Jun 30, 2019 $172.47K